Patent · US Expired

Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

US7060847B2 · kind B2 · utility

0Cited by
5References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 2003
Grant dateJun 13, 2006
Priority date
Expiry dateJul 22, 2024

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/809
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention comprises novel analogs of ecstasy-class compounds and novel ecstasy-class immunogens leashed out of, i.e., derived from, the methylenedioxy position. The invention also comprises unique monoclonal antibodies generated using MDO-leashed MDMA immunogens as well as unique conjugates and tracers. These antibodies, conjugates, and tracers are useful in immunoassays for the detection of ecstasy-class compounds in biological fluids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.